Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pediatric alfuzosin dose-ranging pharmacokinetic study in neuropathic elevated detrusor leak point pressure
2014-004659-30Phase 3
- Sponsor
- Sanofi
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of alfuzosin in neurogenic bladder (2 arms), sponsored by Sanofi. Primary endpoint: Pharmacokinetic parameters.
02
Drugs
alfuzosin
03
Conditions
neurogenic bladder
Beyond the preview
Go deeper on 2014-004659-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004659-30.